Myasthenia gravis MRI

Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Myasthenia gravis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myasthenia Gravis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myasthenia gravis MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myasthenia gravis MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myasthenia gravis MRI

CDC on Myasthenia gravis MRI

Myasthenia gravis MRI in the news

Blogs on Myasthenia gravis MRI

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Myasthenia gravis MRI

Overview

Magnetic resonance imaging (MRI) is also a more sensitive way to identify thymomas. In a case report done by Vasiliki Zouvelou and colleagues, based on MRI findings it was suggested that MG patients with anti-MuSK antibodies are more prone to have facial and bulbar muscle atrophy.

MRI

  • MRI may be helpful in the diagnosis of myasthenia gravis.
  • Magnetic resonance imaging (MRI) is also a more sensitive way to identify thymomas, and are generally done for this reason. Findings on MRI suggestive of MG are mostly thymic masses. So many studies suggested a relationship between myasthenia gravis and thymus. This disease mostly occurs in patients with thymic hyperplasia and thymoma and the removal of thymus can reduce the clinical symptom of the patients. Based on this fact, detection of these thymic masses is very important in management of myasthenia gravis.[1][2][3][4][5]
  • It is suggested that MRI is more accurate than CT scan in differentiating thymic masses.[6]
  • In a case report done by Vasiliki Zouvelou and colleagues, based on MRI findings it was suggested that MG patients with anti-MuSK antibodies are more prone to have facial and bulbar muscle atrophy.[7]

References

  1. Wechsler AS, Olanow CW (August 1980). "Myasthenia gravis". Surg. Clin. North Am. 60 (4): 931–45. PMID 7423369.
  2. Elias SB, Appel SH (July 1979). "Current concepts of pathogenesis and treatment of myasthenia gravis". Med. Clin. North Am. 63 (4): 745–57. PMID 89275.
  3. Mintz S, Petersen SR, MacFarland D, Petajan J, Richards RC (December 1980). "The current role of thymectomy for myasthenia gravis". Am. J. Surg. 140 (6): 734–7. PMID 7457692.
  4. Cohn HE, Solit RW, Schatz NJ, Schlezinger N (December 1974). "Surgical treatment in myasthenia gravis. A 27 year experience". J. Thorac. Cardiovasc. Surg. 68 (6): 876–85. PMID 4421048.
  5. Fraser K, Simpson JA, Crawford J (May 1978). "The place of surgery in the treatment of myasthenia gravis". Br J Surg. 65 (5): 301–4. PMID 647191.
  6. Priola AM, Priola SM, Gned D, Giraudo MT, Fornari A, Veltri A (March 2016). "Comparison of CT and chemical-shift MRI for differentiating thymoma from non-thymomatous conditions in myasthenia gravis: value of qualitative and quantitative assessment". Clin Radiol. 71 (3): e157–69. doi:10.1016/j.crad.2015.12.009. PMID 26774127.
  7. Zouvelou V, Rentzos M, Toulas P, Evdokimidis I (June 2012). "AchR-positive myasthenia gravis with MRI evidence of early muscle atrophy". J Clin Neurosci. 19 (6): 918–9. doi:10.1016/j.jocn.2011.09.022. PMID 22341149.

Template:WH Template:WS